Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation

Abstract

In case of life-threatening bleeding refractory to all conventional therapies, rFVIIa presents an acceptable safety profile in patients under ECMO support. No circuit dysfunctions and limited rates of thromboembolism are observed.